The Role of Familial Mediterranean Fever Gene Mutation in Treatment of Infantile Colitis With Resistant Perianal Fistula
- PMID: 30874249
- PMCID: PMC6409165
- DOI: 10.5606/ArchRheumatol.2018.6741
The Role of Familial Mediterranean Fever Gene Mutation in Treatment of Infantile Colitis With Resistant Perianal Fistula
Abstract
Symptoms of infantile inflammatory bowel disease (I-IBD) can be life-threatening and associated with poor prognosis. The presence of Mediterranean fever (MEFV) gene mutations play an important role in treatment of I-IBD. In this article, we describe a case of I-IBD with a resistant fistula, in which remission occurred following colchicine therapy. The patient was a six-month-girl with complaints of bloody diarrhea and a perianal abscess of three months duration. Laboratory tests revealed elevated inflammatory parameters, hypoalbuminemia, and anemia. Results of repeated viral, bacterial and parasitic analyses were negative. Endoscopic and histopathological examinations confirmed a diagnosis of I-IBD. Although diarrhea episodes decreased following intensive conventional treatment with immunosuppressive therapy and anti-tumor necrosis factor, the perianal abscess and fistula did not resolve. Molecular genetic analysis to identify causes of infantile disease revealed the MEFV gene mutation. Thus, colchicine was added to the treatment regimen. Following treatment with colchicine, defecation returned to normal, and the fistula resolved. The MEFV gene mutation should be investigated in children with infantile colitis and resistant fistulas, particularly in Mediterranean countries. In patients with infantile colitis who have the MEFV gene mutation, colchicine treatment may be an alternative to intensive immunosuppressive therapy.
Keywords: Colchicine; infantile colitis; perianal fistula.
Conflict of interest statement
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Figures


Similar articles
-
MEFV Gene-Related Enterocolitis Account for Some Cases Diagnosed as Inflammatory Bowel Disease Unclassified.Digestion. 2020;101(6):785-793. doi: 10.1159/000502640. Epub 2019 Sep 6. Digestion. 2020. PMID: 31494649
-
The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy.Eur J Pediatr. 2008 Apr;167(4):391-3. doi: 10.1007/s00431-007-0508-x. Epub 2007 May 23. Eur J Pediatr. 2008. PMID: 17520284
-
Neonatal ulcerative colitis associated with Familial Mediterranean fever: a case report.Rheumatol Int. 2018 Jan;38(1):137-140. doi: 10.1007/s00296-017-3848-5. Epub 2017 Oct 13. Rheumatol Int. 2018. PMID: 29027576
-
A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.Orphanet J Rare Dis. 2017 Mar 16;12(1):54. doi: 10.1186/s13023-017-0609-1. Orphanet J Rare Dis. 2017. PMID: 28302131 Free PMC article. Review.
-
[A retrospective analysis of 7 cases of familial mediterranean fever].Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(1):21-27. doi: 10.2177/jsci.40.21. Nihon Rinsho Meneki Gakkai Kaishi. 2017. PMID: 28539550 Review. Japanese.
Cited by
-
The improvement of a refractory enterocutaneous fistula with colchicine in a patient with Crohn's disease who had an MEFV gene mutation.Clin J Gastroenterol. 2025 Feb;18(1):81-88. doi: 10.1007/s12328-024-02061-3. Epub 2024 Nov 20. Clin J Gastroenterol. 2025. PMID: 39567438
References
-
- Sari S, Egritas O, Dalgic B. The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy. Eur J Pediatr. 2008;167:391–393. - PubMed
-
- Egritas O, Dalgic B. Infantile Colitis as a Novel Presentation of Familial Mediterranean Fever Responding to Colchicine Therapy. J Pediatr Gastroenterol Nutr. 2011;53:102–105. - PubMed
Publication types
LinkOut - more resources
Full Text Sources